Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Ovarian Hyperstimulation Syndrome

Health written question – answered on 14th July 2014.

Alert me about debates like this

Photo of Jim Dobbin Jim Dobbin Labour, Heywood and Middleton

To ask the Secretary of State for Health pursuant to the answer of 7 July 2014, Official Report, column 43W, on ovarian hyperstimulation syndrome, what information the Human Fertilisation and Embryology Authority (HFEA) collects about the (a) identity of drugs used in treatment and (b) dosage used and the associated regimen for ovarian stimulation at each clinic; and what comparative assessment he has made of the collection of such data by the HFEA and by other countries that report data to the European Society of Human Reproduction and Embryology.

Photo of Jane Ellison Jane Ellison The Parliamentary Under-Secretary of State for Health

The Human Fertilisation and Embryology Authority has advised that it does not collect information on the identity of drugs used in treatment, the dosage used and the associated regimen for ovarian stimulation at each licensed centre. As a result, no comparison has been made with data collected by countries submitting information to the European Society of Human Reproduction and Embryology.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.